Cargando…

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response

SIMPLE SUMMARY: Natural Killer (NK) cells are innate lymphocytes that play an important role in the immune response against cancer. Their activity is controlled by a balance of inhibitory and activating receptors, which in cancer can be skewed to favor their suppression in support of immune escape....

Descripción completa

Detalles Bibliográficos
Autores principales:	Toffoli, Elisa C., Sheikhi, Abdolkarim, Höppner, Yannick D., de Kok, Pita, Yazdanpanah-Samani, Mahsa, Spanholtz, Jan, Verheul, Henk M. W., van der Vliet, Hans J., de Gruijl, Tanja D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916216/ https://www.ncbi.nlm.nih.gov/pubmed/33572396 http://dx.doi.org/10.3390/cancers13040711

Ejemplares similares

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
por: Veluchamy, John P., et al.
Publicado: (2017)

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study
por: Toffoli, Elisa C., et al.
Publicado: (2021)

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer
por: Veluchamy, John Pradeep, et al.
Publicado: (2016)

In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer
por: Veluchamy, John P., et al.
Publicado: (2017)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
por: van Vliet, Amanda A., et al.
Publicado: (2021)

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status
por: Veluchamy, John P., et al.
Publicado: (2016)

Immunological effects of everolimus in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2017)

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function
por: Veluchamy, John P., et al.
Publicado: (2017)

Specific tumor targeting and activation of Vγ9Vδ2 T cells by bi-specific nanobodies
por: Stam, Anita, et al.
Publicado: (2014)

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma
por: Poels, Renée, et al.
Publicado: (2021)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
por: Goedegebuure, Ruben S.A., et al.
Publicado: (2020)

Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function
por: Mantesso, Simone, et al.
Publicado: (2020)

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer
por: Wentink, Madelon Q, et al.
Publicado: (2016)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2011)

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
por: Lamers-Kok, Nina, et al.
Publicado: (2022)

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34(+) progenitor cell-derived NK cells
por: van Vliet, Amanda A., et al.
Publicado: (2023)

Reciprocal Complementation of the Tumoricidal Effects of Radiation and Natural Killer Cells
por: Yang, Kai-Lin, et al.
Publicado: (2013)

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
por: Huijts, Charlotte M., et al.
Publicado: (2019)

Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells
por: Gerosa, Franca, et al.
Publicado: (2002)

Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential
por: Keller, Christian W., et al.
Publicado: (2017)

Natural adjuvants (PC and G2) induce activated natural killer cells with NKG2D expression and cytotoxic properties in colorectal cancer
por: khodadadi, Ali, et al.
Publicado: (2022)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
por: Huijts, Charlotte M., et al.
Publicado: (2018)

Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
por: Saha, Tanmoy, et al.
Publicado: (2021)

Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T‐cells and tumour cells
por: Del Vecchio, Filippo, et al.
Publicado: (2021)

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression
por: Stolk, Dorian, et al.
Publicado: (2018)

Autohemotherapy in Chronic Urticaria: What Could Be the Autoreactive Factors and Curative Mechanisms?
por: Sheikhi, Abdolkarim, et al.
Publicado: (2014)

Extensive natural killer cell receptor phenotyping on NK and T cells discloses differences in RA and PsA, potentially mirroring diverse immunoregulatory functions
por: van Bijnen, Sandra TA, et al.
Publicado: (2011)

High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
por: Spanholtz, Jan, et al.
Publicado: (2010)

Contemporaneous SARS-CoV-2-Neutralizing Antibodies Mediated by N-glycan Shields
por: Baghaie, Leili, et al.
Publicado: (2023)

Construction of CTLA-4-Ig Fusion Gene in pBudCE4.1 Expression Vector
por: Yazdanpanah-Samani, Mahsa, et al.
Publicado: (2015)

Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells
por: van Dodewaard-de Jong, Joyce M., et al.
Publicado: (2015)

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

HOTAIR Induces the Downregulation of miR-200 Family Members in Gastric Cancer Cell Lines
por: Bossaghzadeh, Fatemeh, et al.
Publicado: (2022)

Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer
por: Fayyaz, Farimah, et al.
Publicado: (2022)

Reciprocity in elastodynamics
por: Achenbach, J D
Publicado: (2003)

Apoptosis induction in acute promyelocytic leukemia cells through upregulation of CEBPα by miR-182 blockage
por: Sharifi, Mohammadreza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_175i9ui2jdtkt44ceag1ae0k46